Under construction – not a live service
Sign in
Taking people in DenmarkPhase 3

Vitamin D in pregnancy to help prevent early childhood asthma

Tests higher-dose vitamin D supplements taken during pregnancy, in pregnant adults.

Plain-language title generated from the registry record
Registry title: VItamin D in pregnanCy for prevenTion Of eaRlY Childhood Asthma

Key facts

Where
Gentofte Municipality, DenmarkSee the site
Phase
Phase 3

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 45 years old?

Source: NCT06570889, who can take part

Where in Denmark

  • Copenhagen University Hospital of CopenhagenGentofte Municipality, DenmarkTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Professor Klaus Bønnelykke
Trial code
NCT06570889
Record updated
30 September 2025
Original description
The overall aim of the study is to develop a nutritional preventive vitamin D supplementation strategy in pregnancy for early childhood asthma/persistent wheeze during the first three years of life as we hypothesize that supplementation in higher doses than recommended could reduce the risk of disease development.Read full original descriptionShow less

VItamin D in pregnanCy for prevenTion Of eaRlY Childhood Asthma (VICTORY)

The overall aim of the study is to develop a nutritional preventive vitamin D supplementation strategy in pregnancy for early childhood asthma/persistent wheeze during the first three years of life as we hypothesize that supplementation in higher doses than recommended could reduce the risk of disease development.

Pregnant Danish women before week 26 with blood levels of EPA+DHA above 4.7% of total fatty acids; No current vitamin D intake above the recommended 400 IU/day; No endocrine-, heart-, kidney- or auto-immune disorders; No disorders requiring treatment with blood thinning medication.

ClinicalTrials.gov NCT06570889